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T
he small GTPases RalA and RalB
are activated downstream of onco-
genic Ras. While activation of RalA is
critically important for tumor initiation
and growth of Ras-driven cancers, the
highly similar small GTPase RalB is
implicated in cell survival and metastasis.
This difference in function between
these two related proteins maps to the
C-terminus, a 30 amino acid region that
regulates subcellular localization and con-
tains several potential phosphorylation
sites. Here we discuss our recent evidence
that phosphorylation by the mitotic
kinase Aurora A promotes RalA relocali-
zation to mitochondrial membranes,
where it recruits the effector RalBP1
and the large dynamin-related GTPase
Drp1 to promote mitochondrial fission.
As upregulation of both RalA and Aurora
A have been observed in human tumors,
and phosphorylation of RalA at the site
targeted by Aurora A promotes tumor-
igenesis, it is possible that regulation of
mitochondrial fission is one mechanism
by which RalA promotes cancer.
Mutations in the RAS gene are present in
nearly one third of all human cancers
and up to 90% of pancreatic cancers.
1
Constitutively active Ras proteins promote
tumorigenesis through the engagement of
downstream effector proteins, including
phosphatidylinositol-3 kinase (PI3K),
2 the
Raf family of serine/threonine kinases,
3-6
and the RalGEF family of guanine nucleo-
tide exchange factors.
7-9 Of these three, the
RalGEF pathway is the least well under-
stood, although mounting evidence points
to a role for this pathway in multiple
aspects of tumorigenesis.
10-18 RalGEFs
comprise a family of six guanine nucleotide
exchange factors (RalGDS, RGL, RGL2/
Rlf, RGL3, RalGPS1 and RalGPS2) of
which all but RalGPS1 and RalGPS2 are
directly activated by Ras.
19 These proteins
promote the activation of two nearly
identical small GTPases, RalA and RalB,
which in turn engage a diverse set of
downstream effector molecules, including
the exocyst components Sec5
20,21 and
Exo84,
22 the large multifunctional RalBP1
(RLIP76/RLIP1/RIP1),
23 the actin cross-
linking protein filamin,
24 and the transcrip-
tion factor ZONAB.
25 Despite 80%
sequence identity, and near 100% identity
in their effector binding domains,
26 RalA
and RalB promote distinct aspects of
tumor growth downstream of oncogenic
Ras. While RalA has been shown to be
important for tumor initiation and growth,
RalB seems to play more of a role in
promoting survival and metastasis.
13,17,27,28
This difference in function between RalA
and RalB maps to the 30 amino acid
hypervariable C-terminus of the protein, as
replacing this region in RalB with that of
RalA is sufficient to impart both the
polarized membrane delivery function, as
well as transforming activity to RalB.
13,29
The hypervariable regions of RalA and
RalB are both highly basic and have a
conserved CAAX motif that targets the
protein for prenylation, but they otherwise
share little sequence identity.
26 Both
sequence analysis and targeted mutational
analysis of these regions have identified
several putative phosphorylation sites that
are unique to either RalA or RalB.
12,13,30,31
These sites are of particular interest, as
analysis of the related small GTPase KRas
suggests that phosphorylation of the
hypervariable domain can have a profound
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impact on subcellular localization and
protein function.
32 Of the two serine
residues in the RalA C-terminus (S183
and S194) and five threonine or serine
residues in the RalB C-terminus (T178,
S182, S192, S193 and S198), several have
been shown to be targets of phosphoryla-
tion,
12,30,31 with the best-characterized
being S194 of RalA. S194 is phosphoryl-
ated by Aurora A, a kinase activated in
mitosis that is known to be important
for mitotic entry, centrosome duplication
and maturation, bipolar spindle assembly
and cytokinesis,
31,33 and can be dephos-
phorylated by the phosphatase PP2A.
30
Phosphorylation of S194 leads to an
increase in active, GTP-bound RalA and
redistributes the protein from the plasma
membrane to internal membranes.
30,31,34
Furthermore, Aurora A cooperates with
RalA to promote tumorigenesis, and
mutating S194 to alanine or dephos-
phorylating S194 by PP2A inhibits RalA
transforming ability.
30,34
In order to better understand the role of
this phosphorylation, we examined the
specific subcellular localization of RalA in
the presence and absence of ectopic Aurora
A. Similar to what was found for KRas
following its phosphorylation by PKC,
32
immunofluorescence analysis of GFP-
tagged RalA and immunoblot analysis of
biochemically fractionated cells revealed
that a portion of RalA localizes at mito-
chondria or membranes tightly associated
with this organelle. Furthermore, expres-
sion of an active (T288D) mutant of
Aurora A or mutation of RalA-S194 to
Aspartic acid to mimic phosphorylation
increased the amount of RalA in the
mitochondria while inhibition of Aurora
A, or mutation of RalA-S194 to Alanine
had the opposite effect.
35
Analysis of the localization of RalA
at mitochondria also revealed a striking
difference in the morphology of mitochon-
dria in cells with activated Aurora A. While
the majority of cells expressing a vector
control exhibited a mixture of long inter-
connected mitochondria and short punctate
mitochondria, cells expressing active Aurora
A
T288D exhibited a large percentage of small
punctate mitochondria. Cells expressing
the kinase-inactive Aurora
K162R,o nt h e
other hand, exhibited a large percentage of
long interconnected mitochondria.
Mitochondrial morphology is main-
tained through a balance of the opposing
processes of fusion and fission and it has
become clear in recent years that main-
taining this balance is critical to a number
of cellular processes and implicated in a
number of human diseases.
36-38 Given that
Aurora A activity promoted the mitochon-
drial localization of RalA and affected
mitochondrial morphology, we performed
both loss-of-function and gain-of-function
analysis and found that RalA was required
for normal mitochondrial dynamics.
Specifically, Aurora A promoted mito-
chondrial division in a RalA and S194
dependent fashion, and expression of the
phosphomimetic RalA
S194D was sufficient
to induce mitochondrial fragmentation.
Furthermore, phosphorylation of RalA by
Aurora A promoted mitochondrial fission,
as opposed to blocking fusion, and was
accompanied by an increase in the levels of
the large, fission-promoting GTPase Drp1
at the mitochondria.
35
Phosphorylation of RalA on S194 was
previously shown to promote the binding
of RalA to RalBP1 over Sec5 and Exo84.
34
Consistent with this, shRNA-mediated
knockdown of RalBP1 phenocopied the
effects of RalA knockdown on mito-
chondrial morphology, promoting long
interconnected networks. Additionally,
expression of active Aurora A
T288D resulted
in an increase in the levels of RalBP1
associated with the mitochondrial fraction.
This increase in mitochondrial RalBP1
was abrogated by knockdown of RalA,
suggesting that RalA recruits RalBP1 to
mitochondria to promote mitochondrial
fission. Indeed fusion of the C-terminus
of RalA in the S194D phosphomimetic
configuration to RalBP1 was sufficient to
promote both mitochondrial localization
and mitochondrial fission.
35
Mitochondrial fission increases during
mitosis, and is dependent on both the
mitochondrial recruitment and phos-
phorylation of Drp1.
39-41 As Aurora A is
active during mitosis,
42 we tested and
found that the levels of S194-phosphory-
lated RalA were increased in mitotic
HeLa cell extracts when compared with
unsynchronized cells and that this phos-
phorylation was coincident with increased
recruitment of RalA, RalBP1, and Drp1
to mitochondrial membranes at mitotis.
Importantly, knockdown of RalA, RalBP1
or Aurora A led to a decrease in Drp1
recruitment to mitochondria during
mitosis, suggesting that this pathway is
critical for the mitotic mitochondrial
recruitment of Drp1.
During mitosis, Drp1 is also phos-
phorylated on S616 by the mitotic kinase
Cyclin B/CDK1.
31 Previous studies have
shown that RalBP1 binds to Cyclin
B/CDK1 and promotes the phosphoryla-
tion of the protein Epsin to suppress
receptor-mediated endocytosis.
43 We con-
firmed that RalBP1 bound to Cyclin B
and associated with CDK1 kinase activity
in mitotic extracts. Furthermore, similar to
its role with Epsin, RalBP1 promoted
CDK1 phosphorylation of Drp1 in vitro,
and loss of RalBP1, but not RalA, decreased
the levels of S616 phosphorylated Drp1 in
mitotic extracts. Importantly, we detected a
complexincluding RalA,RalBP1,Drp1and
Cyclin B on biochemically enriched mito-
chondrial membranes during mitosis, sug-
gesting a model whereby RalBP1 forms a
complex with Drp1 and Cyclin B/CDK1 to
promote Drp1 phosphorylation and this
complex is recruited to mitochondrial
membranes through the binding to S194-
phosphorylated RalA (Fig. 1).
This model predicts that mitotic mito-
chondrial fission will be disrupted in cells
lacking either RalA or RalBP1. Indeed,
while the mitochondria of scramble control
cells underwent fission during metaphase,
mitochondria remained interconnected in
cells in which either RalA or RalBP1 had
been knocked down by shRNA. The
effects of RalA knockdown were rescued
by expression of an shRNA-resistant wild-
type RalA, but not RalA
S194A, underscor-
ing the importance of this phosphoryla-
tion site for mitochondrial fission.
The loss of mitotic mitochondrial
fission in RalA and RalBP1 knockdown
cells often resulted in mitochondrial bridges
between daughter cells during cytokinesis,
which was associated with a failure to
complete cytokinesis and unequal distribu-
tion of mitochondria to the two daughter
cells. Additionally, knockdown cells exhi-
bited signs of mitochondrial dysfunction,
with decreased levels of ATP and reduced
cell growth over time.
35
Notably, upregulation of Aurora A pro-
tein levels
44,45 and RalA activity
10,11,13,46,47
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has been observed in human cancer cells.
Furthermore, knockdown or inhibition of
Aurora A kinase activity impairs tumor
growth,
48,49 and knockdown or inhibition
of RalA reduces Ras-induced transforma-
tion and tumor growth of multiple cancer
cell lines derived from a diverse set of
cancers.
10,11,13,30,46,47,50-52 Importantly, the
loss of Ras-induced tumor formation
following RalA knockdown can be rescued
in most cells by wildtype, but not an
S194A mutant of RalA, confirming the
importance of Aurora A phosphorylation
for this process.
30,31,34 Maintenance of a
dynamic mitochondrial network has been
shown to be important for several cellular
processes that are also known to be critical
for tumorigenesis, including autophagy
and the cargo-specific clearance of mito-
chondria known as mitophagy,
53-56 apop-
tosis
57-59 and maintenance of metabolic
function.
37,60,61 We have shown that
metabolic function is compromised in
cells lacking RalA and RalBP1, ultimately
leading to diminished cellular growth.
35
Taken together, these data suggest the
intriguing possibility that aberrant activa-
tion and phosphorylation of RalA promote
tumor growth, at least in part, through the
regulation of mitochondrial fission. The
finding that the tumor suppressor p53
regulates mitochondrial fission through
down-regulation of miR-499, which nega-
tively regulates Drp1 expression,
62 suggests
that dysregulated mitochondrial dynamics
might be a general feature of cancer cells
and indeed, analysis of cancer cell lines by
electron microscopy has revealed abnormal
mitochondrial morphologies.
63
It will be interesting to test whether, in
addition to metabolic function, autophagy
and apoptosis are also affected by loss of
RalA and RalBP1, and whether their
restoration can rescue the loss of tumor-
igenesis phenotype characteristic of RalA
inhibition. Intriguingly, RalB has been
shown to directly impact both autophagy
64
and apoptosis,
28 through engagement of
Exo84 and Sec5, respectively, however it is
not known how these two related small
GTPases use different effector pathways to
potentially converge on the same cellular
processes and what impact this convergence
may have on Ras-driven tumorigenesis.
If the control of mitochondrial dyna-
mics proves to be important for Ras-driven
tumorigenesis, it could represent an
important step towards discovering a more
effective way to treat cancer. While
inhibition of Ras or other small GTPases
has proven to be problematic as a thera-
peutic strategy,
65 perhaps targeted disrup-
tion of mitochondrial dynamics will prove
Figure 1. Ras activation of RalA leads to engagement of multiple effector pathways. The RalGEF-Ral signaling pathway is a key effector pathway
downstream of activated Ras. Activation of RalA in turn leads to activation of several downstream signaling pathways affecting diverse cellular processes,
including exocytosis, endocytosis, actin dynamics and transcription. New evidence also indicates that following phosphorylation by Aurora A, RalA and its
effector RalBP1 play a key role in the regulation of mitochondrial fission during mitosis by regulating the phosphorylation of Drp1 and its recruitment to
mitochondrial membranes. “*” denotes proteins whose expression or activity have been reported to be elevated in human cancer.
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more pharmacologically feasible. Small
molecule inhibitors of the mitochondrial
fusion and fission machinery, including
the recently described Drp1 inhibitor
Mdivi-1,
66 are under development,
67 and
it will be enlightening to test them in
mouse tumor models to see if they have a
clinical effect on tumor growth.
In conclusion, the finding that phos-
phorylation of RalA promotes mitochon-
drial fission through the recruitment of
RalBP1 and Drp1 to mitochondria repre-
sents an important step forward in our
understanding of RalA function, in
the functional differences between RalA
and RalB, and provides potential insight
into how RalA regulates Ras-mediated
tumorigenesis.
Acknowledgments
We thank Donita Brady for review of the
manuscript. This work was supported by
NIH grant CA94184 (C.M.C.). D.F.K. is a
Leukemia and Lymphoma Society Fellow.
References
1. Bos JL. ras oncogenes in human cancer: a review.
Cancer Res 1989; 49:4682-9; PMID:2547513
2. Rodriguez-Viciana P, Warne PH, Dhand R,
Vanhaesebroeck B, Gout I, Fry MJ, et al. Phospha-
tidylinositol-3-OH kinase as a direct target of Ras.
Nature 1994; 370:527-32; PMID:8052307; http://dx.
doi.org/10.1038/370527a0
3. ZhangXF,SettlemanJ,KyriakisJM,Takeuchi-SuzukiE,
Elledge SJ, Marshall MS, et al. Normal and oncogenic
p21ras proteins bind to the amino-terminal regulatory
domain of c-Raf-1. Nature 1993; 364:308-13;
PMID:8332187; http://dx.doi.org/10.1038/364308a0
4. Han M, Golden A, Han Y, Sternberg PW. C. elegans
lin-45 raf gene participates in let-60 ras-stimulated
vulval differentiation. Nature 1993; 363:133-40;
PMID:8483497; http://dx.doi.org/10.1038/363133a0
5. Warne PH, Viciana PR, Downward J. Direct inter-
action of Ras and the amino-terminal region of Raf-1
in vitro. Nature 1993; 364:352-5; PMID:8332195;
http://dx.doi.org/10.1038/364352a0
6. Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan
DL, Rapp UR, et al. Raf-1 activates MAP kinase-
kinase. Nature 1992; 358:417-21; PMID:1322500;
http://dx.doi.org/10.1038/358417a0
7. Hofer F, Fields S, Schneider C, Martin GS. Activated
Ras interacts with the Ral guanine nucleotide dissoci-
ation stimulator. Proc Natl Acad Sci USA 1994;
91:11089-93; PMID:7972015; http://dx.doi.org/10.
1073/pnas.91.23.11089
8. Spaargaren M, Bischoff JR. Identification of the
guanine nucleotide dissociation stimulator for Ral as a
putative effector molecule of R-ras, H-ras, K-ras, and
Rap. Proc Natl Acad Sci USA 1994; 91:12609-13;
PMID:7809086; http://dx.doi.org/10.1073/pnas.91.
26.12609
9. Kikuchi A, Demo SD, Ye ZH, Chen YW, Williams LT.
ralGDS family members interact with the effector loop
of ras p21. Mol Cell Biol 1994; 14:7483-91; PMID:
7935463
10. Zipfel PA, Brady DC, Kashatus DF, Ancrile BD,
Tyler DS, Counter CM. Ral activation promotes
melanomagenesis. Oncogene 2010; 29:4859-64; PMID:
20562921; http://dx.doi.org/10.1038/onc.2010.224
11. Martin TD, Samuel JC, Routh ED, Der CJ, Yeh JJ.
Activation and involvement of Ral GTPases in
colorectal cancer. Cancer Res 2011; 71:206-15;
PMID:21199803; http://dx.doi.org/10.1158/0008-
5472.CAN-10-1517
12. Wang H, Owens C, Chandra N, Conaway MR,
Brautigan DL, Theodorescu D. Phosphorylation of
RalB is important for bladder cancer cell growth and
metastasis. Cancer Res 2010; 70:8760-9; PMID:
20940393; http://dx.doi.org/10.1158/0008-5472.
CAN-10-0952
13. Lim K-H, Baines AT, Fiordalisi JJ, Shipitsin M,
Feig LA, Cox AD, et al. Activation of RalA is critical for
Ras-induced tumorigenesis of human cells. Cancer Cell
2005; 7:533-45; PMID:15950903; http://dx.doi.org/
10.1016/j.ccr.2005.04.030
14. Chien Y, White MA. RAL GTPases are linchpin modu-
lators of human tumour-cell proliferation and survival.
EMBO Rep 2003; 4:800-6; PMID:12856001; http://dx.
doi.org/10.1038/sj.embor.embor899
15. González-García A, Pritchard CA, Paterson HF, Mavria G,
Stamp G, Marshall CJ. RalGDS is required for tumor
formation in a model of skin carcinogenesis. Cancer Cell
2005; 7:219-26; PMID:15766660; http://dx.doi.org/10.
1016/j.ccr.2005.01.029
16. Jiménez M, Pérez de Castro I, Benet M, García JF,
Inghirami G, Pellicer A. The Rgr oncogene induces
tumorigenesis in transgenic mice. Cancer Res 2004;
64:6041-9; PMID:15342385; http://dx.doi.org/10.
1158/0008-5472.CAN-03-3389
17. Bodemann BO, White MA. Ral GTPases and cancer:
linchpin support of the tumorigenic platform. Nat Rev
Cancer 2008; 8:133-40; PMID:18219307; http://dx.
doi.org/10.1038/nrc2296
18. Hamad NM, Elconin JH,Karnoub AE, Bai W,Rich JN,
Abraham RT, et al. Distinct requirements for Ras
oncogenesis in human versus mouse cells. Genes Dev
2002; 16:2045-57; PMID:12183360; http://dx.doi.org/
10.1101/gad.993902
19. NeelNF, MartinTD, Stratford JK,ZandTP, ReinerDJ,
Der CJ. The RalGEF-Ral effector signaling network:
The road less traveled for anti-Ras drug discovery. Genes
Cancer 2011; 2:275-87; PMID:21779498; http://dx.
doi.org/10.1177/1947601911407329
20. Moskalenko S, Henry DO, Rosse C, Mirey G,
Camonis JH, White MA. The exocyst is a Ral effector
complex. Nat Cell Biol 2002; 4:66-72; PMID:
11740492; http://dx.doi.org/10.1038/ncb728
21. Sugihara K, Asano S, Tanaka K, Iwamatsu A, Okawa K,
Ohta Y. The exocyst complex binds the small GTPase
RalA tomediatefilopodia formation. Nat CellBiol 2002;
4:73-8; PMID:11744922; http://dx.doi.org/10.1038/
ncb720
22. Moskalenko S, Tong C, Rosse C, Mirey G,
Formstecher E, Daviet L, et al. Ral GTPases regulate
exocyst assembly through dual subunit interactions.
J Biol Chem 2003; 278:51743-8; PMID:14525976;
http://dx.doi.org/10.1074/jbc.M308702200
23. Cantor SB, Urano T, Feig LA. Identification and
characterization of Ral-binding protein 1, a potential
downstream target of Ral GTPases. Mol Cell Biol
1995; 15:4578-84; PMID:7623849
24. Ohta Y, Suzuki N, Nakamura S, Hartwig JH,
Stossel TP. The small GTPase RalA targets filamin to
induce filopodia. Proc Natl Acad Sci USA 1999;
96:2122-8; PMID:10051605; http://dx.doi.org/10.
1073/pnas.96.5.2122
25. Frankel P, Aronheim A, Kavanagh E, Balda MS,
Matter K, Bunney TD, et al. RalA interacts with
ZONAB in a cell density-dependent manner and
regulates its transcriptional activity. EMBO J 2005;
24:54-62; PMID:15592429; http://dx.doi.org/10.
1038/sj.emboj.7600497
26. Chardin P, Tavitian A. Coding sequences of human
ralA and ralB cDNAs. Nucleic Acids Res 1989;
17:4380; PMID:2662142; http://dx.doi.org/10.1093/
nar/17.11.4380
27. Lim K-H, O’Hayer K, Adam SJ, Kendall SD,
Campbell PM, Der CJ, et al. Divergent roles for
RalA and RalB in malignant growth of human
pancreatic carcinoma cells. Curr Biol 2006; 16:2385-
94; PMID:17174914; http://dx.doi.org/10.1016/j.cub.
2006.10.023
28. Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW,
Johnson CL, et al. RalB GTPase-mediated activation
of the IkappaB family kinase TBK1 couples innate
immune signaling to tumor cell survival. Cell 2006;
127:157-70; PMID:17018283; http://dx.doi.org/10.
1016/j.cell.2006.08.034
29. Shipitsin M, Feig LA. RalA but not RalB enhances
polarized delivery of membrane proteins to the
basolateral surface of epithelial cells. Mol Cell Biol
2004; 24:5746-56; PMID:15199131; http://dx.doi.
org/10.1128/MCB.24.13.5746-5756.2004
30. Sablina AA, Chen W, Arroyo JD, Corral L, Hector M,
Bulmer SE, et al. The tumor suppressor PP2A Abeta
regulates the RalA GTPase. Cell 2007; 129:969-82;
PMID:17540176; http://dx.doi.org/10.1016/j.cell.
2007.03.047
31. Wu J-C, Chen T-Y, Yu C-TR, Tsai S-J, Hsu J-M,
Tang M-J, et al. Identification of V23RalA-Ser194 as a
critical mediator for Aurora-A-induced cellular motility
and transformation by small pool expression screening.
J Biol Chem 2005; 280:9013-22; PMID:15637052;
http://dx.doi.org/10.1074/jbc.M411068200
32. Bivona TG, Quatela SE, Bodemann BO, Ahearn IM,
Soskis MJ, Mor A, et al. PKC regulates a farnesyl-
electrostaticswitchonK-Rasthatpromotesitsassociation
with Bcl-XL on mitochondria and induces apoptosis.
Mol Cell 2006; 21:481-93; PMID:16483930; http://dx.
doi.org/10.1016/j.molcel.2006.01.012
33. Vader G, Lens S. The Aurora kinase family in cell
division and cancer. Biochim Biophys Acta 2008;
1786:60-72.
34. Lim K-H, Brady DC, Kashatus DF, Ancrile BB,
Der CJ, Cox AD, et al. Aurora-A phosphorylates,
activates, and relocalizes the small GTPase RalA. Mol
Cell Biol 2010; 30:508-23; PMID:19901077; http://
dx.doi.org/10.1128/MCB.00916-08
35. Kashatus DF, Lim K-H, Brady DC, Pershing NLK,
Cox AD, Counter CM. RALA and RALBP1 regulate
mitochondrial fission atmitosis. Nat Cell Biol 2011;
13:1-10; PMID:21173798; http://dx.doi.org/10.1038/
ncb2310
36. Liesa M, Palacín M, Zorzano A. Mitochondrial
dynamics in mammalian health and disease. Physiol
Rev 2009; 89:799-845; PMID:19584314; http://dx.
doi.org/10.1152/physrev.00030.2008
37. Otera H, Mihara K. Molecular mechanisms and
physiologic functions of mitochondrial dynamics. J
Biochem 2011; 149:241-51; PMID:21233142; http://
dx.doi.org/10.1093/jb/mvr002
38. Westermann B. Mitochondrial fusion and fission in cell
life and death. Nat Rev Mol Cell Biol 2010; 11:872-84;
PMID:21102612; http://dx.doi.org/10.1038/nrm3013
39. Arakaki N, Nishihama T, Owaki H, Kuramoto Y,
Suenaga M, Miyoshi E, et al. Dynamics of mitochon-
dria during the cell cycle. Biol Pharm Bull 2006;
29:1962-5; PMID:16946518; http://dx.doi.org/10.
1248/bpb.29.1962
40. Mitra K, Wunder C, Roysam B, Lin G, Lippincott-
Schwartz J. A hyperfused mitochondrial state achieved
at G1-S regulates cyclin E buildup and entry into S
phase. Proc Natl Acad Sci USA 2009; 106:11960-5;
PMID:19617534; http://dx.doi.org/10.1073/pnas.
0904875106
332 Small GTPases Volume 2 Issue 6© 2012 Landes Bioscience.
Do not distribute.
41. Taguchi N, Ishihara N, Jofuku A, Oka T. Mitotic
phosphorylation of dynamin-related GTPase Drp1
participates in mitochondrial fission. J Biol Chem
2007; 282:11521-9; PMID:17301055; http://dx.doi.
org/10.1074/jbc.M607279200
42. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L,
Souza B, et al. A homologue of Drosophila aurora
kinase is oncogenic and amplified in human colorectal
cancers. EMBO J 1998; 17:3052-65; PMID:9606188;
http://dx.doi.org/10.1093/emboj/17.11.3052
43. Rossé C, L’Hoste S, Offner N, Picard A, Camonis J.
RLIP, an effector of the Ral GTPases, is a platform for
Cdk1 to phosphorylate epsin during the switch off of
endocytosis in mitosis. J Biol Chem 2003; 278:30597-
604; PMID:12775724; http://dx.doi.org/10.1074/jbc.
M302191200
44. Fukushige S, Waldman FM, Kimura M, Abe T,
Furukawa T, Sunamura M, et al. Frequent gain
of copy number on the long arm of chromosome
20 in human pancreatic adenocarcinoma. Genes
Chromosomes Cancer 1997; 19:161-9; PMID:
9218997; http://dx.doi.org/10.1002/(SICI)1098-2264
(199707)19:3,161::AID-GCC5.3.0.CO;2-W
45. Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB,
Cleary K, et al. Overexpression of oncogenic STK15/
BTAK/Aurora A kinase in human pancreatic cancer.
Clin Cancer Res 2003; 9:991-7; PMID:12631597
46. Bodempudi V, Yamoutpoor F, Pan W, Dudek AZ,
Esfandyari T, Piedra M, et al. Ral overactivation in
malignant peripheral nerve sheath tumors. Mol Cell
Biol 2009; 29:3964-74; PMID:19414599; http://dx.
doi.org/10.1128/MCB.01153-08
47. Yu Y, Feig LA. Involvement of R-Ras and Ral GTPases
in estrogen-independent proliferation of breast cancer
cells. Oncogene 2002; 21:7557-68; PMID:12386818;
http://dx.doi.org/10.1038/sj.onc.1205961
48. Okada T, Sawada T, Osawa T, Adachi M, Kubota K.
MK615 inhibits pancreatic cancer cell growth by dual
inhibition of Aurora A and B kinases. World J
Gastroenterol 2008; 14:1378-82; PMID:18322951;
http://dx.doi.org/10.3748/wjg.14.1378
49. Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F,
Ohmura N, et al. RNA interference targeting aurora
kinase a suppresses tumor growth and enhances the
taxane chemosensitivityin humanpancreatic cancer cells.
Cancer Res 2005; 65:2899-905; PMID:15805292;
http://dx.doi.org/10.1158/0008-5472.CAN-04-3981
50. Vigil D, Martin TD, Williams F, Yeh JJ, Campbell SL,
Der CJ. Aberrant overexpression of the Rgl2 Ral small
GTPase-specific guanine nucleotide exchange factor
promotes pancreatic cancer growth through Ral-
dependent and Ral-independent mechanisms. J Biol
Chem 2010; 285:34729-40; PMID:20801877; http://
dx.doi.org/10.1074/jbc.M110.116756
51. Yin J, Pollock C, Tracy K, Chock M, Martin P,
Oberst M, et al. Activation of the RalGEF/Ral pathway
promotes prostate cancer metastasis to bone. Mol Cell
Biol 2007; 27:7538-50; PMID:17709381; http://dx.
doi.org/10.1128/MCB.00955-07
52. Sowalsky AG, Alt-Holland A, Shamis Y, Garlick JA,
Feig LA. RalA function in dermal fibroblasts is required
for the progression of squamous cell carcinoma of the
skin. Cancer Res 2011; 71:758-67; PMID:21159665;
http://dx.doi.org/10.1158/0008-5472.CAN-10-2756
53. Gomes LC, Benedetto GD, Scorrano L. During
autophagy mitochondria elongate, are spared from
degradation and sustain cell viability. Nat Cell Biol
2011; 13:589-98; PMID:21478857; http://dx.doi.org/
10.1038/ncb2220
54. Rambold AS, Kostelecky B, Elia N, Lippincott-
Schwartz J. Tubular network formation protects
mitochondria from autophagosomal degradation dur-
ing nutrient starvation. Proc Natl Acad Sci USA 2011;
108:10190-5; PMID:21646527; http://dx.doi.org/10.
1073/pnas.1107402108
55. Youle RJ, Narendra DP. Mechanisms of mitophagy.
Nat Rev Mol Cell Biol 2011; 12:9-14; PMID:
21179058; http://dx.doi.org/10.1038/nrm3028
56. Chen H, Chan DC. Mitochondrial dynamics–fusion,
fission, movement, and mitophagy–in neurodegenerative
diseases. Hum Mol Genet 2009; 18:R169-76; PMID:
19808793; http://dx.doi.org/10.1093/hmg/ddp326
57. Sheridan C, Martin SJ. Mitochondrial fission/fusion
dynamics and apoptosis. Mitochondrion 2010; 10:640-
8; PMID:20727425; http://dx.doi.org/10.1016/j.mito.
2010.08.005
58. Wasilewski M, Scorrano L. The changing shape of
mitochondrial apoptosis. Trends Endocrinol Metab
2009; 20:287-94; PMID:19647447; http://dx.doi.org/
10.1016/j.tem.2009.03.007
59. Youle RJ, Karbowski M. Mitochondrial fission in
apoptosis. Nat Rev Mol Cell Biol 2005; 6:657-63;
PMID:16025099; http://dx.doi.org/10.1038/nrm1697
60. Campello S, Scorrano L. Mitochondrial shape changes:
orchestrating cell pathophysiology. EMBO Rep 2010;
11:678-84; PMID:20725092; http://dx.doi.org/10.
1038/embor.2010.115
61. Parone PA, Da Cruz S, Tondera D, Mattenberger Y,
James DI, Maechler P, et al. Preventing mitochondrial
fission impairs mitochondrial function and leads to loss
of mitochondrial DNA. PLoS ONE 2008; 3:e3257;
PMID:18806874; http://dx.doi.org/10.1371/journal.
pone.0003257
62. Wang J-X, Jiao J-Q, Li Q, Long B, Wang K, Liu J-P,
et al. miR-499 regulates mitochondrial dynamics by
targeting calcineurin and dynamin-related protein-1.
Nat Med 2011; 17:71-8; PMID:21186368; http://dx.
doi.org/10.1038/nm.2282
63. Arismendi-Morillo G. Electron microscopy morpho-
logy of the mitochondrial network in gliomas and their
vascular microenvironment. Biochim Biophys Acta
2011; 1807:602-8.
64. Bodemann BO, Orvedahl A, Cheng T, Ram RR,
Ou Y-H, Formstecher E, et al. RalB and the exocyst
mediate the cellular starvation response by direct
activation of autophagosome assembly. Cell 2011;
144:253-67; PMID:21241894; http://dx.doi.org/10.
1016/j.cell.2010.12.018
65. Cox AD. Ras history: The saga continues. Small
GTPases 2010; 1:2-27; PMID:21686117; http://dx.
doi.org/10.4161/sgtp.1.1.12178
66. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C,
Yoo C, Kuwana T, et al. Chemical inhibition of the
mitochondrial division dynamin reveals its role in Bax/
Bak-dependent mitochondrial outer membrane per-
meabilization. Dev Cell 2008; 14:193-204; PMID:
18267088; http://dx.doi.org/10.1016/j.devcel.2007.
11.019
67. Zorzano A, Sebastián D, Segalés J, Palacín M. The
molecular machinery ofmitochondrial fusion andfission:
An opportunity for drug discovery? Curr Opin Drug
Discov Devel 2009; 12:597-606; PMID:19736619
www.landesbioscience.com Small GTPases 333